Patent · US Active

Small molecule inhibitors selective for polo-like kinase proteins

US11597737B2 · kind B2 · utility

0Cited by
10References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2020
Grant dateMar 7, 2023
Priority date
Expiry dateApr 27, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are small molecule PLK inhibitors that can target the polo box domain (PBD). Inhibitors can have an atomic mass of about 1000 Da or less and a general structure of For instance, the inhibitors can include an alkyl benzamido benzoic acid core structure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.